Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.

Quercetin is a unique dietary polyphenol because it can exert biphasic dose-responses on cells depending on its concentration. Cancer preventative effects of quercetin are observed at concentrations of approximately 1-40 microM and are likely mediated by quercetin's antioxidant properties. Pro-oxidant effects are present at cellular concentrations of 40-100 microM. However, at higher concentrations, many novel pathways in addition to ROS contribute to its effects. The potent bioactivity of quercetin has led to vigorous study of this compound and revealed numerous pathways that could interact synergistically to prevent or treat cancer. The effect of intake and concentration on emerging pathways and how they may interact are discussed in this review.

[1]  M. Benito,et al.  P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. , 2003, Molecular biology of the cell.

[2]  T. Inakuma,et al.  Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans. , 2007, The journal of medical investigation : JMI.

[3]  S. Groshen,et al.  GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. , 2006, Cancer research.

[4]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.

[5]  J. Reynolds,et al.  The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down‐regulating the expression of heat shock protein 90 , 2008, The Prostate.

[6]  J. Buring,et al.  Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. , 2009, The American journal of clinical nutrition.

[7]  Qiang Zhang,et al.  Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[8]  L. Mira,et al.  Plasma quercetin metabolites: structure-antioxidant activity relationships. , 2004, Archives of biochemistry and biophysics.

[9]  G. Rimbach,et al.  Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. , 2008, The Journal of nutrition.

[10]  Takuji Tanaka,et al.  Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. , 2010, Chemico-biological interactions.

[11]  C. Rice-Evans,et al.  Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. , 2003, The Biochemical journal.

[12]  A. von Deimling,et al.  Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. , 2009, Neuro-oncology.

[13]  H. Hua,et al.  Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70 , 2008, Journal of cellular and molecular medicine.

[14]  G. Williams,et al.  A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  A. S. Sreedhar,et al.  Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma. , 2009, Biochemical pharmacology.

[16]  J. Terao,et al.  Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. , 2003, Archives of biochemistry and biophysics.

[17]  M. Marino,et al.  Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. , 2009, Molecular nutrition & food research.

[18]  Chee Pang Ng,et al.  Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation. , 2004, International journal of oncology.

[19]  J. Gustafsson,et al.  A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells , 2008, Oncogene.

[20]  R. Burd,et al.  Quercetin Selectively Inhibits Bioreduction and Enhances Apoptosis in Melanoma Cells That Overexpress Tyrosinase , 2007, Nutrition and cancer.

[21]  J. Segura-Aguilar,et al.  Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. , 1999, Free radical biology & medicine.

[22]  U. Oppermann,et al.  Three-dimensional Structure and Enzymatic Function of Proapoptotic Human p53-inducible Quinone Oxidoreductase PIG3* , 2009, The Journal of Biological Chemistry.

[23]  G. Williamson,et al.  Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. , 2003, Biochemical pharmacology.

[24]  A. Ström,et al.  Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERα/ERβ ratio , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  T. Ito,et al.  Protein synthesis inhibition by flavonoids: roles of eukaryotic initiation factor 2alpha kinases. , 1999, Biochemical and biophysical research communications.

[26]  D. Kerr,et al.  Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  L. Goya,et al.  Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2) , 2006, European journal of nutrition.

[28]  A. Scalbert,et al.  Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. , 2005, Life sciences.

[29]  Adam P Dicker,et al.  Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  S. Wolffram,et al.  Tissue distribution of quercetin in pigs after long-term dietary supplementation. , 2008, The Journal of nutrition.

[31]  C. Shaha,et al.  Oestrogen modulates human macrophage apoptosis via differential signalling through oestrogen receptor‐α and β , 2009 .

[32]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[33]  S. Kuo,et al.  Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells , 2009, Human & experimental toxicology.

[34]  Bochu Wang,et al.  Regulation of Survivin and Bcl‐2 in HepG2 Cell Apoptosis Induced by Quercetin , 2009, Chemistry & biodiversity.

[35]  S. Ebeler,et al.  Quercetin inhibits hydrogen peroxide-induced DNA damage and enhances DNA repair in Caco-2 cells. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  J. Vervoort,et al.  Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. , 2000, Archives of biochemistry and biophysics.

[37]  R. Burd,et al.  Tyrosinase Overexpression Promotes ATM-Dependent p53 Phosphorylation by Quercetin and Sensitizes Melanoma Cells to Dacarbazine , 2008, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[38]  T. Mak,et al.  Specific Ablation of the Apoptotic Functions of Cytochrome c Reveals a Differential Requirement for Cytochrome c and Apaf-1 in Apoptosis , 2005, Cell.

[39]  Yahong Lin,et al.  TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. , 2002, Genes & development.

[40]  B. Shin,et al.  Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model , 2008, Pharmaceutical Research.

[41]  C. Hunt,et al.  Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. , 2009, Journal of medicinal chemistry.

[42]  H. Jang,et al.  Protective Mechanism of Quercetin and Rutin Using Glutathione Metabolism on H2O2‐induced Oxidative Stress in HepG2 Cells , 2009, Annals of the New York Academy of Sciences.

[43]  T. Walle,et al.  Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. , 2005, The Journal of nutrition.

[44]  P. Proksch,et al.  Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. , 2005, The Journal of nutrition.

[45]  Qiang Zhang,et al.  Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  H. Wajant,et al.  The Fas Signaling Pathway: More Than a Paradigm , 2002, Science.

[47]  A. Bast,et al.  Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. , 2003, Biochemical and biophysical research communications.

[48]  C. Shaha,et al.  Oestrogen modulates human macrophage apoptosis via differential signalling through oestrogen receptor-alpha and beta. , 2009, Journal of cellular and molecular medicine.

[49]  M. Rodríguez-Gómez,et al.  Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats , 2008, British journal of pharmacology.